A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Inhibition Analysis and High-Resolution Crystal Structure of Mus musculus Glutathione Transferase P1-1




TekijätKupreienko Oleksii, Pouliou Fotini, Konstandinidis Konstantinos, Axarli Irene, Douni Eleni, Papageorgiou Anastassios C., Labrou Nikolaos E.

KustantajaMDPI

Julkaisuvuosi2023

JournalBiomolecules

Tietokannassa oleva lehden nimiBIOMOLECULES

Lehden akronyymiBIOMOLECULES

Artikkelin numero 613

Vuosikerta13

Numero4

Sivujen määrä15

eISSN2218-273X

DOIhttps://doi.org/10.3390/biom13040613

Verkko-osoitehttps://doi.org/10.3390/biom13040613

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/179811672


Tiivistelmä

Multidrug resistance is a significant barrier that makes anticancer therapies less effective. Glutathione transferases (GSTs) are involved in multidrug resistance mechanisms and play a significant part in the metabolism of alkylating anticancer drugs. The purpose of this study was to screen and select a lead compound with high inhibitory potency against the isoenzyme GSTP1-1 from Mus musculus (MmGSTP1-1). The lead compound was selected following the screening of a library of currently approved and registered pesticides that belong to different chemical classes. The results showed that the fungicide iprodione [3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide] exhibited the highest inhibition potency (ΙC50 = 11.3 ± 0.5 μΜ) towards MmGSTP1-1. Kinetics analysis revealed that iprodione functions as a mixed-type inhibitor towards glutathione (GSH) and non-competitive inhibitor towards 1-chloro-2,4-dinitrobenzene (CDNB). X-ray crystallography was used to determine the crystal structure of MmGSTP1-1 at 1.28 Å resolution as a complex with S-(p-nitrobenzyl)glutathione (Nb-GSH). The crystal structure was used to map the ligand-binding site of MmGSTP1-1 and to provide structural data of the interaction of the enzyme with iprodione using molecular docking. The results of this study shed light on the inhibition mechanism of MmGSTP1-1 and provide a new compound as a potential lead structure for future drug/inhibitor development.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 13:50